Market Research
Turn interviews, reports, transcripts, and research outputs into structured findings and strategic narratives.
Market, competitive, patient, HCP, KOL, brand, and asset intelligence embedded directly into decision workflows.
Strategic intelligence should not wait for disconnected research cycles. Improzo turns fragmented market and external signals into decision-ready intelligence.
Strategy teams in pharma carry some of the most consequential decisions in the organization — portfolio direction, competitive positioning, patient targeting, and asset prioritization. The challenge is not analytical capability. It is that the intelligence needed to act arrives too slowly, too fragmented, and too disconnected to drive decisions in real time.
Strategic decisions are still shaped by fragmented research cycles, competitive updates, patient journey work, HCP segmentation, and portfolio analysis. Strategic Intelligence creates a more continuous way to interpret market movement and turn it into decision-ready narratives.
Turn interviews, reports, transcripts, and research outputs into structured findings and strategic narratives.
Track competitor activity across messaging, science, launches, market movement, and external sources.
Map barriers, drop-offs, access issues, experience signals, and segment-level differences.
Organize HCP segments, KOL influence, activity patterns, and engagement context.
Support BD, licensing, and portfolio teams with faster views of asset, market, and competitive fit.
Strategic Intelligence uses advanced AI to continuously monitor, structure, and surface market, competitive, and portfolio signals — so strategy teams spend less time compiling intelligence and more time acting on it.
Bring market, competitive, patient, HCP, KOL, brand, and asset intelligence into always-on decision workflows.
Converts research inputs, interviews, reports, and documents into decision-ready intelligence.
Monitors competitor movement across messaging, market activity, science, and external signals.
Structures patient journey barriers, drop-offs, access issues, and experience signals.
Builds structured intelligence around HCP segments, KOL activity, and influence patterns.
Supports BD, licensing, and portfolio teams with faster asset and market intelligence.
Converts research inputs, interviews, reports, and documents into decision-ready intelligence.
Monitors competitor movement across messaging, market activity, science, and external signals.
Structures patient journey barriers, drop-offs, access issues, and experience signals.
Builds structured intelligence around HCP segments, KOL activity, and influence patterns.
Supports BD, licensing, and portfolio teams with faster asset and market intelligence.
How life sciences organizations are moving beyond analytics into agentic AI systems that actively execute, optimize, and adapt in real time.
Cofounder and Chief Technology Officer
Cofounder and Chief Executive Officer